Clinical Trials Browser

Phase 3 × Leukemia, B-Cell × obinutuzumab × Clear all

NCT04608318 2024-12-31

CLL17

Phase 3 Active not recruiting

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT03836261 2024-12-27

AMPLIFY

Phase 3 Active not recruiting

984 enrolled 1 FDA

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell